Effects of anti-tuberculosis drugs on the proliferation and differentiation of alveolar stem cells.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2025-09-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.taap.2025.117546PMID 40935086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PHB2 promotes colorectal cancer cell proliferation and tumorigenesis through NDUFS1-mediated oxidative phosphorylation

  2023cited by this paper
• Targeting glutamine metabolism as a therapeutic strategy for cancer

  2023cited by this paper
• Drug-induced interstitial lung disease

  2022cited by this paper
• SARS-CoV-2 Infection and Lung Regeneration

  2022cited by this paper
• Glutamine Metabolism Is Required for Alveolar Regeneration during Lung Injury

  2022cited by this paper
• Metabolic linkages between zinc exposure and lung cancer risk: A nested case-control study.

  2022cited by this paper
• Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death

  2022cited by this paper
• Biosynthesis pathways and strategies for improving 3-hydroxypropionic acid production in bacteria

  2021cited by this paper
• Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids.

  2021cited by this paper
• Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis.

  2020cited by this paper
• Cellular stress responses and dysfunctional Mitochondrial–cellular senescence, and therapeutics in chronic respiratory diseases

  2020cited by this paper
• Autophagy Reprograms Alveolar Progenitor Cell Metabolism in Response to Lung Injury

  2020cited by this paper
• Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury

  2020cited by this paper
• Regulation of alveolar type 2 stem/progenitor cells in lung injury and regeneration.

  2020cited by this paper
• Mitochondrial Damage and the Road to Exhaustion.

  2020cited by this paper
• Lung regeneration by multipotent stem cells residing at the bronchioalveolar-duct junction

  2019cited by this paper
• New aspects of amino acid metabolism in cancer

  2019cited by this paper
• Role of lysophosphatidic acid in proliferation and differentiation of intestinal epithelial cells

  2019cited by this paper
• Metabolic regulation of cell growth and proliferation

  2019cited by this paper
• NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis

  2019cited by this paper
• Macrophages and lipid metabolism

  2018cited by this paper
• Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies.

  2018cited by this paper
• Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation

  2017cited by this paper
• Energy Metabolism Plays a Critical Role in Stem Cell Maintenance and Differentiation

  2016cited by this paper
• Liver glucose metabolism in humans

  2016cited by this paper
• Establishing a synthetic pathway for high-level production of 3-hydroxypropionic acid in Saccharomyces cerevisiae via β-alanine.

  2015cited by this paper
• Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update

  2014cited by this paper
• p63+Krt5+ distal airway stem cells are essential for lung regeneration

  2014cited by this paper
• Type 2 alveolar cells are stem cells in adult lung.

  2013cited by this paper
• Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.

  2013cited by this paper
• Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation

  2012cited by this paper
• Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin.

  2011cited by this paper
• Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

  2011cited by this paper
• Epithelial progenitor cells in lung development, maintenance, repair, and disease.

  2011cited by this paper
• Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice.

  2011cited by this paper
• Recent advances in the biological production of mannitol

  2009cited by this paper
• ABC transporters: the power to change

  2009cited by this paper
• Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways Published, JLR Papers in Press, November 24, 2008.

  2009cited by this paper
• Endogenous lung stem cells and contribution to disease

  2009cited by this paper
• Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review

  2008cited by this paper
• Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms.

  2007cited by this paper
• Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

  2007cited by this paper
• Expression of Cathelicidin LL-37 during Mycobacterium tuberculosis Infection in Human Alveolar Macrophages, Monocytes, Neutrophils, and Epithelial Cells

  2007cited by this paper
• Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis

  2007cited by this paper
• The roles of cilia in developmental disorders and disease

  2006cited by this paper
• Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism.

  2006cited by this paper
• Identification of bronchioalveolar stem cells in normal lung and lung cancer.

  2005cited by this paper
• Parathyroid hormone-related protein reduces alveolar epithelial cell proliferation during lung injury in rats.

  2000cited by this paper
• Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids.

  1999cited by this paper
• Pharmacokinetics of Ethambutol under Fasting Conditions, with Food, and with Antacids

  1999cited by this paper
• Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids.

  1999cited by this paper
• Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide

  1997cited by this paper
• Effect of L-alanine and some other amino acids on thymocyte proliferation in vivo.

  1993cited by this paper
• Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins.

  1989cited by this paper
• Clinical Pharmacokinetics of the Antituberculosis Drugs

  1984cited by this paper

• No citing papers are available for this paper.